Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
See also
Vaccine recommendation
20/09/2022
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
xrvCsTdukHy8wc5T